Amisulpride T0811
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Amisulpride�(trade name�Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approve
CAS nr:
71675-85-9
Purity:
98%
Molecular Weight:
369,49
SMILES:
CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC
Formula:
C17H27N3O4S
Pathway:
GPCR/G Protein,Neuroscience,GPCR/G Protein,Neuroscience
Target:
5-HT Receptor,5-HT Receptor,Dopamine Receptor,Dopamine Receptor



